Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease

72Citations
Citations of this article
151Readers
Mendeley users who have this article in their library.

Abstract

Cholesterol-rich, apolipoprotein B (apoB)-containing lipoproteins are now widely accepted as the most important causal agents of atherosclerotic cardiovascular disease. Multiple unequivocal and orthogonal lines of evidence all converge on low-density lipoprotein and related particles as being the principal actors in the genesis of atherosclerosis. Here, we review the fundamental role of atherogenic apoB-containing lipoproteins in cardiovascular disease and several other humoral and parietal factors that are required to initiate and maintain arterial degeneration. The biology of foam cells and their interactions with high-density lipoproteins, including cholesterol efflux, are also briefly reviewed.

Cite

CITATION STYLE

APA

Fazio, S., & Shapiro, M. D. (2017). Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Research. Faculty of 1000 Ltd. https://doi.org/10.12688/f1000research.9845.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free